CareCloud, Inc. 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock - CCLDO STOCK NEWS

CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has scheduled its third quarter 2024 financial results release for November 12, 2024, before market opening. The company will host an investor conference call at 8:30 a.m. Eastern Time the same day. Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only by dialing 201-389-0920. A replay will be available approximately one hour after the call's conclusion.

CareCloud, Inc. (Nasdaq: CCLD) has announced a strategic partnership with ChartSwap to launch 'CareCloud Powered by ChartSwap', a new solution aimed at streamlining the Request for Information (ROI) process in healthcare. This collaboration will enable ChartSwap to serve as the dedicated portal for handling medical records requests at CareCloud provider locations.

Key benefits of the partnership include:

• Seamless request handling through a centralized portal
• Enhanced security and compliance with privacy standards
• Improved efficiency for providers by reducing administrative burden
• Real-time transparency and tracking for requestors

The partnership aims to simplify practice management, allowing healthcare providers to focus more on patient care while ensuring efficient and secure management of medical records requests.

CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leading healthcare technology solutions provider, has announced the approval of its Series A Preferred Stock Proposal at a reconvened special meeting. Shareholders representing over two-thirds of the outstanding Series A Preferred Stock approved the proposal, which includes an amendment to the Company's Certificate of Designations, Preferences and Rights of its Series A Preferred Stock.

The approval marks a significant development for CareCloud, potentially impacting its capital structure and shareholder rights. Investors are advised to review the complete Definitive Proxy Statement and related materials filed with the SEC for comprehensive details about the changes and their implications.

CareCloud, Inc. (Nasdaq: CCLD) announced that it has obtained approximately 99% of the minimum required 'FOR' votes by proxy for its Series A Preferred Stock Proposal. The company has received supportive proxy indications from over 2.97 million shares, nearing the required 3.02 million share threshold. If approved, the proposal would grant Series A Preferred Stock holders similar change of control protections as Series B Preferred Stock holders, align dividend structures, and allow the company to exchange Series A shares for common stock at $25/share plus accrued dividends.

The Special Meeting is scheduled for September 11, 2024, but may be adjourned if more time is needed for vote solicitation. Shareholders can still submit voting instructions through various methods. CareCloud emphasizes the importance of reviewing the full Definitive Proxy Statement and related SEC filings for complete information.

CareCloud (Nasdaq: CCLD) announced that 89% of proxies returned for the Series A Preferred Stock special meeting support the Preferred Stock Proposal. The meeting is rescheduled for September 11, 2024. With 87.8% of the required 3.02 million proxy votes received, the company is close to approval. If passed, Series A Preferred Stock holders would gain change of control protections similar to Series B holders, and the dividend would mirror Series B Preferred Stock. The company would also gain the right to exchange Series A shares for common stock at $25/share plus accrued dividends. While optimistic, CareCloud cannot predict final voting results, and unvoted shares count as 'no' votes.

CareCloud Inc (Nasdaq: CCLD) reported its Q2 2024 financial results, showing improvements in profitability and cash flow. Key highlights include:

- GAAP net income of $1.7 million, compared to a net loss of $1.8 million in Q2 2023
- Adjusted EBITDA of $6.4 million, up 67% from Q2 2023
- Revenue of $28.1 million, slightly down from $29.4 million in Q2 2023
- Year-to-date free cash flow of $4.9 million, a 265% increase from the same period last year

The company has identified $26 million in annualized expense reductions and reduced its credit facility balance to $2.5 million. CareCloud aims to further improve profitability and eliminate debt in the coming months.

CareCloud (Nasdaq: CCLD) announced the continuation of proxy solicitation from Series A Preferred Shareholders to approve an amendment to the Certificate of Designations, Preferences and Rights of its Series A Preferred Stock. As of August 2, 2024, 38% of Series A Preferred Stock shares have returned proxies, with 87% in favor of the Preferred Stock Proposal.

If approved, Series A Preferred Stock holders would receive similar change of control protections as Series B Preferred Stock holders. The proposal also includes aligning the Series A dividend with Series B and granting the Company the right to exchange Series A shares for common stock at $25/share plus accrued dividends.

To pass, the proposal needs approval from 66.67% of outstanding Series A Preferred Stock. Voting is open until August 21, 2024. The Company cautions that future results may differ from current trends.

CareCloud, Inc. (Nasdaq: CCLD, CCLDO, CCLDP), a leader in healthcare technology and generative AI solutions for medical practices and health systems, has announced it will release its financial results for Q2 2024 on August 13, 2024, before the market opens. The company will host a conference call for investors at 8:30 a.m. Eastern Time on the same day.

Investors can access the live webcast and presentation slides at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920. A replay of the call and slides will be available approximately one hour after the call concludes at the same link, with an audio-only replay accessible by dialing 412-317-6671 and using access code 13747693.

CareCloud (Nasdaq: CCLD) announced the continuation of proxy solicitation for its Series A Preferred Stock proposal. With 20% of shares voted, 82% favor the changes, up from 72% last week. The proposal requires approval from two-thirds of outstanding shares (about 3 million of 4.5 million) by August 21, 2024. If approved, Series A holders would receive similar change of control protections as Series B holders, and the dividend would mirror Series B. The company would gain the right to exchange Series A shares for common stock at $25/share plus accrued dividends. Voting can be done by phone, online, or mail. The company cautions that future results may vary and non-votes count as 'no' votes.